Gilead (GILD) calls active into late stage NASH study fails
Tweet
Share
E-mail
Get Alerts GILD Hot Sheet
Price: $129.61 --0%
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 2.3%
EPS Growth %: -464.2%
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 2.3%
EPS Growth %: -464.2%
Join SI Premium – FREE
Gilead Sciences (NASDAQ: GILD) February call option implied volatility is at 25, March is at 26, compared to its 52-week range of 19 to 43 into late stage NASH study fails. Call put ratio 4 calls to 1 put.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- HSBC Upgrades Gilead Sciences (GILD) to Buy
- Chubb Corp. (CB) call put ratio 1 call to 1 put as share price down 1.3%
- Rivian Automotive (RIVN) call put ratio 2.2 calls to 1 puts into announcing 75M share equity offering
Create E-mail Alert Related Categories
OptionsRelated Entities
OptionsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
